Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.975 USD | -1.25% | -4.81% | -83.06% |
05-09 | EFFECTOR Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-04 | Health Care Down on Retreat From Risk -- Health Care Roundup | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-83.06% | 9.41M | |
+6.68% | 111B | |
+11.00% | 106B | |
-13.01% | 22.24B | |
+0.52% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-10.40% | 16.81B | |
+39.08% | 12.54B | |
-24.75% | 8.09B |
- Stock Market
- Equities
- EFTR Stock
- News eFFECTOR Therapeutics, Inc.
- Credit Suisse Lowers eFFECTOR Therapeutics' Price Target to $16 from $20 to Reflect Changes in Tomivosertib Program, Keeps Outperform Rating